Ster­ling builds up its API ca­pac­i­ty with big buy of No­var­tis cam­pus in Ire­land

A mas­sive 111-acre man­u­fac­tur­ing site in Ire­land owned by No­var­tis has been ac­quired by Ster­ling Phar­ma So­lu­tions, fur­ther bol­ster­ing its ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) ca­pac­i­ty and pro­vid­ing ex­pand­ed ac­cess for cus­tomers.

The site is in Ringask­id­dy, rough­ly 30 min­utes from Cork, Ire­land, and right now man­u­fac­tures APIs in three dif­fer­ent build­ings on the cam­pus, and has the ca­pac­i­ty to scale-up op­er­a­tions and space for R&D. The deal will in­clude a sup­ply agree­ment be­tween Ster­ling and No­var­tis. The work­force will tran­si­tion to Ster­ling em­ploy­ees once the deal clos­es, the com­pa­ny said. Chief Com­mer­cial Of­fi­cer An­drew Hen­der­son said in an email to End­points News that the site’s fo­cus in small mol­e­cule ser­vice and its sim­i­lar­i­ty to ca­pa­bil­i­ties al­ready-owned sites in Northum­ber­land, UK and Wis­con­sin all made the deal more at­trac­tive to his team.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER